Should Directors Shine Light on Dark Money?

Discussion Board 2 is based on Case 19: Should Directors Shin" rel="nofollow">ine Light on Dark Money? Read the case and concisely answer the followin" rel="nofollow">ing questions: 1. What is your reaction to the PhRMA problem? What would you do if you were the CEO of a pharmaceutical company? 2. What is your reaction to the Target situation? How would you handle it if you were the CEO? 3. Do you agree with Ira Millstein" rel="nofollow">in? Should companies require trade associations to disclose this in" rel="nofollow">information before they join" rel="nofollow">in? Should companies then disclose the in" rel="nofollow">information they receive? If a trade association refuses to provide that in" rel="nofollow">information, should the company refuse to join" rel="nofollow">in?